Unique ID issued by UMIN | UMIN000000664 |
---|---|
Receipt number | R000000800 |
Scientific Title | Supplemental Benefit of ARB in Maintenance of Sinus Rhythm after Left Atrial Ablation in Atrial Fibrillation using Valsartan |
Date of disclosure of the study information | 2007/04/02 |
Last modified on | 2007/03/31 14:00:54 |
Supplemental Benefit of ARB in Maintenance of Sinus Rhythm after Left Atrial Ablation in Atrial Fibrillation using Valsartan
SURV Trial
Supplemental Benefit of ARB in Maintenance of Sinus Rhythm after Left Atrial Ablation in Atrial Fibrillation using Valsartan
SURV Trial
Japan |
Atrial Fibrillation
Cardiology |
Others
NO
To investigate the efficacy of Valsartan in maintenance of sinus rhythm after left atrial ablation for hypertensive patients with atrial fibrillation
Safety,Efficacy
A composite of all - reverse remodeling of left atrium and recurrence of atrial fibrillation.
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
YES
NO
Institution is not considered as adjustment factor.
YES
Numbered container method
2
Treatment
Medicine |
Valsartan40-80mg daily, during the study period.
Control
30 | years-old | <= |
70 | years-old | >= |
Male and Female
Patients who meet all of the following criteria
(1) symptomatic AF patients with at least two kinds of drug-resistance
(2)Patients who are aged 30 years or older and less than 70 years at the entry
(3) Patients without ischemic cardiovascular disease, valvular disease and cardiomyopathy.
(1)Patients who have renal dysfunction (serum creatinine>=3.0mg/dL or those who are receiving chronic hemodialysis
(2) History of drug hypersensitivity to angiotensine II receptor blocker.
(3)Patients who have severe liver dysfunction
(4)Patents with cerebrovasucular disease
(5)History of angioedema
(6)History of malignant tumor or life threatening illness of poor prognosis
(7)Pregnant or possibly pregnant patients
(8)Patents after Cardiovascular surgery
(9)Other patients deemed unsuitable as subjects of the study by the treating physician
180
1st name | |
Middle name | |
Last name | Hiroaki Shimokawa |
Tohoku University Graduate School of Medicine
Department of Cardiovascular Medicine
1-1 Seiryou-machi, Sendai-city
022(717)7153
1st name | |
Middle name | |
Last name | Koji Kumagai |
Tohoku University Graduate School of Medicine
Department of Cardiovascular Medicine
1-1 Seiryou-machi, Sendai-city
Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine
None
Self funding
NO
2007 | Year | 04 | Month | 02 | Day |
Unpublished
Preinitiation
2006 | Year | 11 | Month | 20 | Day |
2007 | Year | 04 | Month | 01 | Day |
2010 | Year | 03 | Month | 01 | Day |
2007 | Year | 03 | Month | 31 | Day |
2007 | Year | 03 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000800
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |